A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)
Clinical trial NCT05686239 · COMPLETED
Trial details
- NCT number
- NCT05686239
- Sponsor
- Recognify Life Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2025-04-09
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.